Skip to main content
Corporate navigation
Company
Sustainability
Investors
Careers
Newsroom
International
US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
Italiano
EN
Mobile: Main menu
BACK
Immunodiagnostics
Immunodiagnostics
BACK
Overview
Infectious diseases
Gastrointestinal diseases
Hepatitis and retroviruses
Endocrinology
Metabolic disorders
Tumor Markers
Instruments
BACK
Instruments
LIAISON
®
XL
LIAISON
®
XS
Dialog
Molecular Diagnostics
Molecular Diagnostics
BACK
Overview
Technologies
BACK
Technologies
VERIGENE
®
NanoGrid Technology
Simplexa™ Real-Time PCR
xTAG
®
and NxTAG
®
Technology
Instruments
BACK
Instruments
LIAISON
®
MDX
The VERIGENE
®
System
Kits and Reagents
BACK
Kits and Reagents
By Disease State
BACK
By Disease State
Bloodstream
CNS
Gastrointestinal
Genetics
Healthcare-Associated Infections
Respiratory
Women’s Health
By Format
BACK
By Format
Molecular Primer Pairs
Molecular Controls
Molecular Reagents
Dialog
Product Documentation
Licensed Technologies
Licensed Technologies
BACK
Overview
xMAP
®
Technology
BACK
xMAP
®
Technology
Applications
BACK
Applications
xMAP
®
Assay Automation
Bead-Based Multiplexing
Immunogenicity
xMAP
®
Microspheres
Instruments
BACK
Instruments
FLEXMAP 3D
®
System
Luminex
®
200™ System
MAGPIX
®
System
xMAP INTELLIFLEX
®
Reagents & Accessories
BACK
Reagents & Accessories
xMAP
®
Kit Finder
Microspheres
BACK
Microspheres
MagPlex-TAG™ Microspheres
MagPlex
®
Microspheres
MagPlex
®
-Avidin Microspheres
MagPlex
®
Monitoring Microspheres
MicroPlex
®
Microspheres
SeroMAP
TM
Microspheres
Coupling Accessories
BACK
Coupling Accessories
xMAP
®
Antibody Coupling Kit
Magnetic separators
xPONENT
®
Software
Product documentation
Service & Support
Service & Support
BACK
Overview
Immunodiagnostics
Molecular Diagnostics
Licensed Technologies
BACK
Licensed Technologies
Field Service Training Sessions
Maintenance & Support
Luminex Learning Sessions
LuminexPLORE Lab
Mobile: Corporate navigation
Company
Sustainability
Investors
Careers
Newsroom
Mobile: Company
BACK
Company
Who we are
BACK
Who we are
Our Story
Our sustainability strategy
Leadership
BACK
Leadership
Michele Denegri
Carlo Rosa
Chen Even
Angelo Rago
Piergiorgio Pedron
Stefano Ronchi
Ugo Gay
Business Model
Specialists in Innovation
Governance
BACK
Governance
Governance documents
BACK
Governance documents
By-Laws
Procedures
Code of Ethics and Model 231
Reports on Corporate Governance
Corporate bodies
Shareholders' meeting
Remuneration
BACK
Remuneration
Reports on remuneration
Information Documents Incentive Plans
Internal dealing operations
Buy back program
Ownership structure
BACK
Ownership structure
Total shareholders’ basis
Loyalty shares
Financial calendar
Transparency Obligations
Diasorin worldwide
Mobile: Sustainability
BACK
Sustainability
Material issues
BACK
Material issues
Worker health and safety
Handling relations with local communities
Staff training and development
Employment and dialog with social partners
Staff well-being
Diversity and inclusion
Environmental management
Business ethics, fight against corruption and anti-competitive behavior
Research, innovation and technological excellence
Customer satisfaction
Product and process quality
Human Rights
ESG
Objectives
Resources
Mobile: Investors
BACK
Investors
Financial corner
BACK
Financial corner
Results
Press releases
Presentations
Annual & Interim Reports
Bond
Coverage
Keep in touch
Calendar
Stock price
Stock market indices and trading codes
Information documents
Mobile: Careers
BACK
Careers
Merit Principles
BACK
Merit Principles
Our Culture
Diversity & Inclusion
People Strategy
Join us
Unisciti a noi
Mobile: Newsroom
BACK
Newsroom
Press Releases
Press Kit
Video gallery
Image gallery
International
US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
Italiano
EN
Main menu
BACK
Immunodiagnostics
Immunodiagnostics
BACK
Overview
Infectious diseases
Gastrointestinal diseases
Hepatitis and retroviruses
Endocrinology
Metabolic disorders
Tumor Markers
Instruments
BACK
Instruments
LIAISON
®
XL
LIAISON
®
XS
Dialog
Molecular Diagnostics
Molecular Diagnostics
BACK
Overview
Technologies
BACK
Technologies
VERIGENE
®
NanoGrid Technology
Simplexa™ Real-Time PCR
xTAG
®
and NxTAG
®
Technology
Instruments
BACK
Instruments
LIAISON
®
MDX
The VERIGENE
®
System
Kits and Reagents
BACK
Kits and Reagents
By Disease State
BACK
By Disease State
Bloodstream
CNS
Gastrointestinal
Genetics
Healthcare-Associated Infections
Respiratory
Women’s Health
By Format
BACK
By Format
Molecular Primer Pairs
Molecular Controls
Molecular Reagents
Dialog
Product Documentation
Licensed Technologies
Licensed Technologies
BACK
Overview
xMAP
®
Technology
BACK
xMAP
®
Technology
Applications
BACK
Applications
xMAP
®
Assay Automation
Bead-Based Multiplexing
Immunogenicity
xMAP
®
Microspheres
Instruments
BACK
Instruments
FLEXMAP 3D
®
System
Luminex
®
200™ System
MAGPIX
®
System
xMAP INTELLIFLEX
®
Reagents & Accessories
BACK
Reagents & Accessories
xMAP
®
Kit Finder
Microspheres
BACK
Microspheres
MagPlex-TAG™ Microspheres
MagPlex
®
Microspheres
MagPlex
®
-Avidin Microspheres
MagPlex
®
Monitoring Microspheres
MicroPlex
®
Microspheres
SeroMAP
TM
Microspheres
Coupling Accessories
BACK
Coupling Accessories
xMAP
®
Antibody Coupling Kit
Magnetic separators
xPONENT
®
Software
Product documentation
Service & Support
Service & Support
BACK
Overview
Immunodiagnostics
Molecular Diagnostics
Licensed Technologies
BACK
Licensed Technologies
Field Service Training Sessions
Maintenance & Support
Luminex Learning Sessions
LuminexPLORE Lab
Home
Company
Governance
Governance documents
Reports on Corporate Governance
Reports on Corporate Governance
Select by year
2019
2012
2011
2010
03/04/2019
Corporate Governance Report FY 2018
1.22 MB
Download
08/02/2019
Report on Corporate Governance 2020
1.13 MB
Download
30/03/2012
Corporate Governance Report 2011
193.94 KB
Download
06/04/2011
Corporate Governance Report 2010
223.52 KB
Download
09/04/2010
Corporate Governance Report 2009
151.14 KB
Download